The chemical class known as V1RE10 activators encompasses a range of compounds that can influence the function of the V1RE10 protein, a member of the vomeronasal type 1 receptor family. These activators are not directly engaging with the receptor but can modulate various signaling pathways that are crucial for the protein's activation. The primary mode of action for these activators involves cellular signaling cascades traditionally associated with G protein-coupled receptors (GPCRs), to which V1RE10 belongs. These activators can enhance or inhibit the activity of enzymes such as adenylyl cyclase, phosphodiesterases, protein kinases, and phospholipases, thereby altering the levels of intracellular second messengers like cyclic AMP (cAMP) and calcium ions. By adjusting the concentrations of these messengers inside the cell, V1RE10 activators can influence the receptor's signaling output.
Such modulations can result in varied intracellular events, such as changes in protein kinase activity or alterations in calcium signaling, which are pivotal in the receptor's ability to respond to its natural ligands. Additionally, some of these activators can interact with G protein subunits directly, either activating or inhibiting them, which further affects the signaling pathways associated with V1RE10. The influence on these pathways can alter the receptor's conformation or its cellular environment, thus modulating its activity. The breadth of this chemical class is significant because it includes compounds that can manipulate different aspects of the receptor's signaling environment, providing multiple angles from which the receptor's activity can be modulated. The complex nature of V1RE10's activation mechanism underscores the diverse potential of these activators to modulate its function through indirect but significant interactions within its signaling network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which could possibly activate Vmn1r67 through enhanced PKA activity that modulates GPCR function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A nonspecific inhibitor of phosphodiesterases, it prevents cAMP breakdown, which could possibly activate Vmn1r67 by sustaining elevated PKA activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Direct activator of protein kinase C (PKC), which could possibly activate Vmn1r67 by modulating downstream GPCR signaling pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A cell-permeable calcium chelator that could possibly activate Vmn1r67 by modulating intracellular calcium levels, affecting calcium-related signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), which could possibly activate Vmn1r67 by increasing cytosolic calcium levels impacting signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that could possibly activate Vmn1r67 by increasing intracellular calcium concentration, influencing calcium-dependent mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A calcium ionophore that could possibly activate Vmn1r67 by mimicking the action of calcium mobilizing agents, affecting signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inactivates certain G proteins, which could possibly activate Vmn1r67 by altering the signaling balance. | ||||||